
|Slideshows|December 19, 2018
Impact of Canagliflozin on Renoprotection in T2DM
Author(s)Veronica Hackethal MD
Will SGLT2 inhibitor canagliflozin prove renoprotective in T2DM patients? CANVAS study authors sought to find out.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement








































































